Your browser doesn't support javascript.
Endoscopy in inflammatory bowel diseases during the COVID-19 pandemic and post-pandemic period.
Iacucci, Marietta; Cannatelli, Rosanna; Labarile, Nunzia; Mao, Ren; Panaccione, Remo; Danese, Silvio; Kochhar, Gursimran S; Ghosh, Subrata; Shen, Bo.
  • Iacucci M; Institute of Translational of Medicine, Institute of immunology and immunotherapy and NIHR Biomedical Research Centre, University of Birmingham and University Hospitals Birmingham NHS Foundation Trust, UK; Department of Gastroenterology and Hepatology, University of Calgary, Calgary, AB, Canada.
  • Cannatelli R; Institute of Translational of Medicine, Institute of immunology and immunotherapy and NIHR Biomedical Research Centre, University of Birmingham and University Hospitals Birmingham NHS Foundation Trust, UK; Department of Gastroenterology, Spedali Civili of Brescia, Italy.
  • Labarile N; Institute of Translational of Medicine, Institute of immunology and immunotherapy and NIHR Biomedical Research Centre, University of Birmingham and University Hospitals Birmingham NHS Foundation Trust, UK; Section of Gastroenterology, Department of Emergency and Organ Transplantation, University of
  • Mao R; Department of Gastroenterology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China; Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, OH, USA.
  • Panaccione R; Department of Gastroenterology and Hepatology, University of Calgary, Calgary, AB, Canada.
  • Danese S; IBD Center, Department of Gastroenterology, Humanitas Clinical and Research Center, IRCCS, Rozzano, Milan, Italy; Department of Biomedical Sciences, Humanitas University, Milan, Italy.
  • Kochhar GS; Department of Gastroenterology, Hepatology & Nutrition, Allegheny Health Network, Pittsburgh, PA, USA.
  • Ghosh S; Institute of Translational of Medicine, Institute of immunology and immunotherapy and NIHR Biomedical Research Centre, University of Birmingham and University Hospitals Birmingham NHS Foundation Trust, UK; Department of Gastroenterology and Hepatology, University of Calgary, Calgary, AB, Canada. Ele
  • Shen B; Center for Inflammatory Bowel Disease, Columbia University Irving Medical Center/New York-Presbyterian Hospital, New York, NY, USA.
Lancet Gastroenterol Hepatol ; 5(6): 598-606, 2020 06.
Article in English | MEDLINE | ID: covidwho-66269
ABSTRACT
The coronavirus disease 2019 (COVID-19) pandemic is changing the management of many chronic diseases, including that of patients with inflammatory bowel diseases (IBD). In particular, the performance of routine endoscopy is temporarily suspended, and only emergency endoscopy is allowed in many countries where severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread. We highlight different scenarios in which endoscopy should still be performed urgently in patients with IBD, as well as recommendations regarding the use of personal protective equipment. We suggest a pathway for performing safe endoscopy and discuss the potential risks of postponing endoscopy in IBD. Finally, we propose a post-pandemic plan for access to endoscopy.
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Inflammatory Bowel Diseases / Endoscopy, Digestive System / Coronavirus Infections Type of study: Diagnostic study / Observational study / Prognostic study Limits: Humans Language: English Journal: Lancet Gastroenterol Hepatol Year: 2020 Document Type: Article Affiliation country: S2468-1253(20)30119-9

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Inflammatory Bowel Diseases / Endoscopy, Digestive System / Coronavirus Infections Type of study: Diagnostic study / Observational study / Prognostic study Limits: Humans Language: English Journal: Lancet Gastroenterol Hepatol Year: 2020 Document Type: Article Affiliation country: S2468-1253(20)30119-9